Clinical Trials on Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients in Canada
Total 8 results
-
Advanced Accelerator ApplicationsTerminatedBreast Cancer | Doxorubicin Induced CardiomyopathyCanada
-
AHS Cancer Control AlbertaTerminatedPeripheral Neuropathy in Breast Cancer PatientCanada
-
McGill University Health Centre/Research Institute...UnknownThe Role of Multimedia on Retention and Comprehension of Key Concepts for Surgical Options in Newly Diagnosed Breast Cancer Patients.Canada
-
Unity Health TorontoHoffmann-La RocheUnknownStage I-IV Breast Cancer (Neo-adjuvant, Adjuvant, Locally Advanced and Metastatic)Canada
-
University of CalgaryTerminated
-
Nova Scotia Health AuthorityCanadian Institutes of Health Research (CIHR); Canadian Cancer Society (CCS)RecruitingCardiovascular Diseases | Cardiotoxicity | Cancer, BreastCanada
-
University Health Network, TorontoCanadian Institutes of Health Research (CIHR); MSH-UHN AMO Innovation FundTerminatedBreast Cancer | Heart Failure, Systolic | Left Ventricular DysfunctionCanada
-
Montreal Heart InstituteAstraZenecaRecruitingLymphoma | Leukemia | Breast CancerCanada